, Tracking Stock Market Picks
Enter Symbol:
Genzyme General (GENZ) [hlAlert]

up 5.28 %

Genzyme General (GENZ) rated Buy by UBS

Posted on: Wednesday,  Feb 3, 2010  8:25 AM ET by UBS

UBS rated Buy Genzyme General (NASDAQ: GENZ) on 02/03/2010. Previously UBS rated Buy Genzyme General (NASDAQ: GENZ) on 07/01/2008., when
the stock price was $72.42. Since then, Genzyme General has gained 5.29% as of 04/08/2011's recent price of $76.25.
If you would have followed the previous UBS's recommendation on GENZ, you would have gained 5.28% of your investment in 1011 days.

Genzyme Corporation is a global biotechnology company dedicated to making a major positive impact on the lives of people with serious diseases. The company's broad product portfolio is focused on rare genetic disorders, renal disease, and osteoarthritis, and includes an industry-leading array of diagnostic products and services. Genzyme's commitment to innovation continues today with research into novel approaches to cancer, heart disease, and other areas of unmet medical need.

UBS is the leading global wealth manager, a top tier investment banking and securities firm, and one of the largest global asset managers. In Switzerland, UBS is the market leader in retail and commercial banking. With headquarters in Zurich and Basel, Switzerland, UBS operates in over 50 countries and from all major international centers. UBS employs more than 80,000 people.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/3/2010 8:25 AM Buy
as of 12/31/2010
1 Week up  0.56 %
1 Month up  0.50 %
3 Months up  1.11 %
1 YTD up  46.05 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/1/2008 8:25 AM Buy

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy